Lynch, Kate D.
Royal Adelaide Hospital · University of Oxford · Oxford University Hospitals NHS Trust · The University of Adelaide
3 papers on CoChatORCID 0000-0001-7748-2165
Most cited papers
- Verified
Obeticholic acid-a new therapy in PBC and NASH
Chapman, R. W., & Lynch, K. D. (2020) · British Medical Bulletin
Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment
Cited by 116
- Verified
Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
Lynch, K. D., Chapman, R. W., Keshav, S., Montano-Loza, A. J., Mason, A. L., Kremer, A. E., Vetter, M., de Krijger, M., Ponsioen, C. Y., Trivedi, P., et al. (2020) · Clinical Gastroenterology and Hepatology
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 105
- Verified
Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis
Hedin, C. R. H., Sado, G., Ndegwa, N., Lytvyak, E., Mason, A., Montano-Loza, A., Gerussi, A., Saffioti, F., Thorburn, D., Nilsson, E., et al. (2020) · Clinical Gastroenterology and Hepatology
Inflammatory Bowel DiseaseLiver Diseases and Immunity
Cited by 52
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free